KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Verisign (VRSN) Research & Development (2016 - 2025)

Verisign (VRSN) has disclosed Research & Development for 17 consecutive years, with $26.5 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Research & Development rose 6.43% year-over-year to $26.5 million, compared with a TTM value of $103.6 million through Dec 2025, up 7.14%, and an annual FY2025 reading of $103.6 million, up 7.14% over the prior year.
  • Research & Development was $26.5 million for Q4 2025 at Verisign, up from $25.4 million in the prior quarter.
  • Across five years, Research & Development topped out at $26.5 million in Q4 2025 and bottomed at $19.6 million in Q3 2021.
  • Average Research & Development over 5 years is $22.9 million, with a median of $22.9 million recorded in 2022.
  • Peak annual rise in Research & Development hit 16.95% in 2021, while the deepest fall reached 0.55% in 2021.
  • Year by year, Research & Development stood at $20.8 million in 2021, then grew by 3.37% to $21.5 million in 2022, then grew by 6.51% to $22.9 million in 2023, then rose by 8.73% to $24.9 million in 2024, then increased by 6.43% to $26.5 million in 2025.
  • Business Quant data shows Research & Development for VRSN at $26.5 million in Q4 2025, $25.4 million in Q3 2025, and $25.7 million in Q2 2025.